首页 产品目录 分子砌块 按官能团 NH-唑类 13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate

13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate

13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
1g 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

79517-01-4

英文名称

13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate

别名

SANDOSTATIN;SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);Octreotide (D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-SoMatostatin-14 (5-12), SMS-201-995;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxyMethyl)propyl]-

标准英文名

13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate

分子式

C53H74N10O14S2

分子量

1139.36

精确分子量

1138.48

SMILES

CC(=O)O.CC(=O)O.CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(NC(=O)C(N)CC2=CC=CC=C2)CSSCC(C(=O)N[C@H](CO)[C@@H](C)O)NC1=O

标准SMILES

CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CSSCC(NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)C(N)CC1C=CC=CC=1.CC(O)=O.CC(O)=O

用途

Octreotide is primarily used for the treatment of esophageal variceal bleeding due to portal hypertension, acromegaly, gastrointestinal bleeding (including bleeding from liver cirrhosis, esophageal varices, peptic ulcers, and stress ulcers), pancreatic diseases (such as severe acute pancreatitis, pancreatic fistula after pancreatic trauma or surgery), and prevention of complications following pancreatic surgery. It is also used for gastrointestinal fistulas, gastroenteropancreatic endocrine tumors (including VIPomas, gastrinomas, glucagonomas, ectopic ACTH syndrome, and carcinoid syndrome), acromegaly, Graves' ophthalmopathy, persistent and refractory diarrhea after total colectomy, and AIDS-related diarrhea. Additionally, intrathecal administration of octreotide can be used for the management of cancer-related pain.

InChIKey

QWFYIFWTVZFPRY-AARKYNAGSA-N

安全信息

SureRoute逆合成路线

1.  79517-01-4 逆合成路线 1

—
—
ACITHJ893
79517-01-4
来源: SureRoute

2.  79517-01-4 逆合成路线 2

—
—
ACITHJ893
79517-01-4
来源: SureRoute

3.  79517-01-4 逆合成路线 3

—
—
ACITHJ893
79517-01-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手